- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06317532
Effect of Functional Exercises on Pain and Quality of Life in Females With Primary Dysmenorrhea
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primary dysmenorrhea and menstrual pain are significant health, social and economic problems. It involves a broad spectrum of physical and emotional manifestations, with 50% to 91 % prevalence in young women.
Women with primary dysmenorrhea report significantly lower quality of life because of bodily pain, general health condition, and physical and social functioning. It compromises the most common gynecological alternations and is the primary cause of women's academic and work absenteeism, which reduces the quality of life, daily activities, and economic situation due to decreased working hours.
Non-Steroidal Anti-Inflammatory Drugs are the first therapeutic line for primary dysmenorrhea; however, they might be accompanied by undesirable side effects, such as dyspepsia, headache, and drowsiness.
So, there is a need for safe interventions with no side effects. Therefore, this study aims to investigate the effects of functional exercises on pain and quality of life in females with primary dysmenorrhea.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Mai Mohamed Ali, PhD
Study Contact Backup
- Name: Manar E. Al-Emary, M.Sc. Stud
- Phone Number: +20 128 660 0931
- Email: manaralemary@gmail.com
Study Locations
-
-
-
Giza, Egypt
- Cairo University
-
Contact:
- Mai Mohamed Ali, PhD
-
Contact:
- Manar E. Al-Emary, M.Sc. Stud
- Phone Number: +20 128 660 0931
- Email: manaralemary@gmail.com
-
Principal Investigator:
- Soheir Mahmoud Elkosery, Prof.
-
Principal Investigator:
- Amr Hazem Abbassy, Assis. Prof.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Their ages will be ranged from 18 to 25 years
- They will be suffering from primary dysmenorrhea based on the Menstrual Distress questionnaire.
- Their BMI will be ranged from 20 to 25 kg/m2.
- Having regular menstrual cycles (one every 28-34 days).
- They will be sedentary virgin females.
- They are non-smokers.
- They have not been in any exercise program for three months.
Exclusion Criteria:
- Having secondary dysmenorrhea.
- Using regular medication or contraceptive pills.
- Having neuromuscular, metabolic, or cardiac diseases.
- Having a preexisting condition prevents them from engaging in an exercise program.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Lifestyle modification advice
It will include 29 females suffering from primary dysmenorrhea.
They will be asked to follow lifestyle modification advice during the program duration.
|
All female participants in groups A and B will be provided with lifestyle modification advice, including recommendations such as reducing caffeine intake, limiting salt consumption, decreasing animal fat consumption, quitting smoking, practicing relaxation techniques, applying heat when needed, considering the use of herbal agents, avoiding cold drinks and foods, and opting for loose, cotton clothing.
|
|
Experimental: Lifestyle modification advice + Functional exercises
It will include 29 females suffering from primary dysmenorrhea.
They will be given the same lifestyle modification advice as group A, in addition to performing a combination of various functional exercises (including two stretching exercises, one yoga position, two core-strengthening exercises, two pelvic area exercises, and Kegel exercises), for 45 minutes per session, three times /week for eight weeks.
|
All female participants in groups A and B will be provided with lifestyle modification advice, including recommendations such as reducing caffeine intake, limiting salt consumption, decreasing animal fat consumption, quitting smoking, practicing relaxation techniques, applying heat when needed, considering the use of herbal agents, avoiding cold drinks and foods, and opting for loose, cotton clothing.
Each female in group (B) will perform the exercise program three times a week for eight weeks at the University Women's Health Unit Exercise protocols mainly consist of relaxation, strengthening, stretching, aerobic exercises, pelvic floor muscle strengthening exercises, yoga, and Pilates
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Menstrual Distress Questionnaire
Time Frame: 8 weeks
|
It will be used to evaluate menstruation symptoms and distress for each female in both groups (A&B) before and after the end of treatment.
It consists of symptoms or feelings associated with menstruation.
The total number of items is 47.
It is a 5-point rating scale from 0-4.
Each item has five options, i.e., No, mild, moderate, severe, and very severe.
An option of (very severe) has a score of 4, (severe) has a score of 3, (moderate) has a score of 2, (mild) has a score of 1, (No) has a score of 0. It includes seven subscales as (pain, water retention, autonomic reactions, negative affect, impaired concentration, mood and behavioral changes, and arousal control).
The overall score was interpreted as follows: <50 - mild, 50 to 70 - moderate, and >70 severe.
|
8 weeks
|
|
Visual analogue scale (VAS)
Time Frame: 8 weeks
|
It will be used to measure pain intensity for each female in both groups (A&B) before and after the end of treatment.
The VAS is usually presented as a 10 cm horizontal line on which the participants' pain intensity is represented by a point between the extremes of "no pain at all "and "worst pain imaginable.
" Its simplicity, reliability, and validity, as well as its ratio scale properties, make the VAS the optional tool for describing pain intensity.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pressure pain threshold assessment
Time Frame: 8 weeks
|
A pressure algometry will be used to measure pressure pain thresholds for all participants in both groups (A&B) before and after the end of the treatment program.
|
8 weeks
|
|
Quality of life enjoyment and satisfaction questionnaire
Time Frame: 8 weeks
|
It will be used to assess health-related quality of life for participants of both groups (A&B) before and after the end of the treatment program.
It consists of items that evaluate overall enjoyment and satisfaction regarding; Physical Health, mood, work, household and leisure activities, family and social relationships, ability to function in daily life, economic status, living or housing situation, ability to get around physically, ability to do work or hobbies, and overall sense of being.
Responses will be scored on a five-point scale (from "very poor" to "very good"), where higher scores indicate better enjoyment and satisfaction with life.
Scores will be added and presented as a percentage of the total maximum score.
A percentage of the total score of > 70 represents the normal quality of life.
|
8 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T.REC/012/004766
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Dysmenorrhea
-
Ankara UniversityThe Scientific and Technological Research Council of TurkeyNot yet recruiting
-
University of SharjahNot yet recruiting
-
Cairo UniversityRecruitingPrimary DysmenorrheaEgypt
-
Cairo UniversityCompletedPrimary DysmenorrheaEgypt
-
Camilo Jose Cela UniversityNot yet recruiting
-
Cairo UniversityNot yet recruitingPrimary DysmenorrheaEgypt
-
Rana Salem Abdelghany AliCompletedPrimary DysmenorrheaEgypt
-
University of HailHealth Education Research Foundation (HERF)Recruiting
-
Dr. Mehak NaeemUniversity of Health Sciences LahoreRecruiting
-
ApexCPG LLCNot yet recruitingPrimary Dysmenorrhea | Menstural CrampsIndia
Clinical Trials on Lifestyle modification advice
-
Chinese University of Hong KongCompletedObstructive Sleep ApneaChina
-
Cairo UniversityNot yet recruiting
-
Northwestern UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHyperglycemia | Glucose Metabolism Disorders | Metabolic Diseases | Obesity | Diabetes Mellitus | Endocrine System Diseases | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Signs and SymptomsUnited States
-
Massachusetts General HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University of OuluOulu University Hospital; Oulu Deaconess Institute Foundation srCompletedObesity | Physical Activity | Weight Loss | Healthy Obesity, MetabolicallyFinland
-
Copenhagen University Hospital at HerlevCompleted
-
Necmettin Erbakan UniversityActive, not recruitingChronic Venous Insufficiency C2 and BelowTurkey (Türkiye)
-
University of PennsylvaniaSt. Luke's-Roosevelt Hospital CenterCompletedObesity | OverweightUnited States
-
Clínica BazterricaWithdrawn
-
Maastricht Radiation OncologyWithdrawnNon Small Cell Lung Cancer